Try our Advanced Search for more refined results
Intellectual Property UK
-
September 11, 2025
Berlin Subway Operator Beats Challenge To Jingle TM
Berlin's main public transportation operator has convinced a European court that its jingle deserves trademark protection after a previous bid failed, because the two-second melody was a striking sequence that the public would remember and recognize.
-
September 10, 2025
Nina Ricci Beats 'Nina Menorca' EU Cosmetics TM
A Spanish cosmetics heavyweight has convinced European officials to nix a company's trademark application for "nina Menorca," after showing that shoppers might believe there was a link to its Nina Ricci brand.
-
September 10, 2025
Glenmark Generic Blocked In Netherlands Over Early Launch
Novartis has convinced a Dutch court to stop Glenmark from making or selling a generic medication used to treat low blood platelet levels in the Netherlands after appearing to launch the drug before Novartis' intellectual property rights had expired.
-
September 10, 2025
Microsoft Defends Software Resale Tactics Amid £270M Claim
Microsoft urged a tribunal on Wednesday to reject a software reseller's claim that the technology giant owes £270 million ($365 million) for restricting the rights of software companies to resell software they have licensed from Microsoft.
-
September 10, 2025
Thai Brewer Stops Singha TM Amid 'Unpleasant' Loo Roll Link
The brewer of Singha beer has persuaded European Union officials to block an opponent's "Singha" trademark application, as the EU Intellectual Property Office ruled that its proposed use on toilet paper could tarnish the Thai drink's brand.
-
September 10, 2025
UPC Classifies Lawyers' Billing Hours As Confidential Info
The Unified Patent Court has ruled that lawyers' billing hours and charging rates count as confidential information, allowing sides to a dispute to keep details of their legal spend out of the public eye.
-
September 09, 2025
Microsoft Cannot Restrict Software Aftermarket, Reseller Says
Counsel for an English software reseller argued at the competition tribunal in London on Tuesday that Microsoft is stifling the legal resale of its software licenses, kicking off the company's antitrust and intellectual property claim.
-
September 09, 2025
Tether Accuses Crypto Trader Of Unlawful Suit Over Bitcoin JV
Tether accused a crypto trading company in a London court on Tuesday of knowingly bringing an unlawful claim over a soured bitcoin mining joint venture after the trader conceded that it did not own the intellectual assets of the joint venture vehicle.
-
September 09, 2025
Oncology Biotech Sues Rival Over Cancer-Testing Patent
An American oncology biotechnology company has sued a Swiss rival for patent infringement, arguing that the medical software business' cancer test and "cutting-edge" platform to accurately analyze data about a patient's blood sample was actually ripping off its technology.
-
September 09, 2025
Diazyme Fends Off Challenge To Vitamin D Testing Patent
European officials have dismissed a law firm's claim that a patent for a vitamin D testing method does nothing new, since Diazyme Laboratories Inc. had eliminated the need for a tedious washing process.
-
September 09, 2025
French Cosmetics Biz Denies Copying Rival's LED Mask
A French cosmetics company has denied copying a British competitor's LED light-therapy mask designs, telling a London court that it had no intention of duping its rival's customers.
-
September 09, 2025
Apple Swerves UPC Claim Over Location-Tagging Tech
A patent monetization firm has dropped its infringement action against Apple at the Unified Patent Court, withdrawing its claim that the technology giant had used vital location-tagging technology without permission.
-
September 15, 2025
HGF Ramps Up Europe Expansion With 3 IP Partners
HGF Ltd. has welcomed three new patent partners to its Munich and Paris offices, after securing a private equity investment in its bid to grow in the European intellectual property space.
-
September 08, 2025
Taylor Wessing Munich Partners Launch New IP Boutique
Five German patent partners at Taylor Wessing LLP are poised to leave the firm in the fall to launch their own legal outfit called Pentarc.
-
September 08, 2025
Family Biz Hits Back At Builder's Bid To Claw Back TM Fees
A family firm has asserted that a trademark for "Miller Metcalfe" was properly transferred to it despite a homebuilder's claims, giving it every right to collect £150,000 ($203,225) in license fees over five years.
-
September 08, 2025
Jimmy Choo Loses Challenge To 'CHHU' Jewelry TM
Designer shoemaker Jimmy Choo has lost its bid to block a "chhu" trademark for jewelry after European Union officials found consumers would be able to distinguish between the two.
-
September 08, 2025
BASF Fends Off Syngenta Challenge To Crop Protection IP
Chemicals giant BASF has fought off the latest challenge by Syngenta Crop Protection AG to its patent for a way of controlling fungi in crops, convincing an appeals board that the patent is new over a series of earlier blueprints for similar pesticides.
-
September 08, 2025
Baker McKenzie Steers Servier On $450M Autism Drug Buy
French pharmaceutical group Servier said Monday it has acquired a potential treatment for the most common genetic cause of autism from U.K.-based biotech Kaerus Bioscience Ltd., in a transaction that could be worth up to $450 million.
-
September 05, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen professional boxing promoter Boxxer take action against the former head of boxing at Matchroom Sport, Aegis Motor Insurance and Chubb European Group clash over a reinsurance claim, and a transgender pool player sue the English Blackball Pool Federation over its decision to ban her competing in women's teams and tournaments.
-
September 05, 2025
Edwards Lifesciences Settles Heart Valve Patent Spat
Edwards Lifesciences has settled its Unified Patent Court dispute with rivals Sintec and Value Med, with the companies agreeing not to sell prosthetic heart valves that infringe Edwards' IP in Europe.
-
September 05, 2025
Sabadell Can't Nix Swiss Investment Firm's TM
Spanish bank Sabadell failed to convince European officials to nix an investment firm's mark for the letter "B" because the fact that its own mark also contained a "B" wasn't enough to make the public think that their financial services were somehow linked.
-
September 05, 2025
Top Commercial Dispute Cases To Watch In The Rest Of 2025
Litigators will be eagerly awaiting the first "dieselgate" trial in what will be the largest ever group action in England and Wales when the courts return after the summer recess, as well as keeping an eye out for the outcome of a £36 billion ($49 billion) claim against BHP. Here, Law360 looks at those and other big cases to watch out for the rest of 2025.
-
September 05, 2025
Arkema Unit Beats Appeal For EU Hydrogenation Patent
Mexican chemical company Mexichem Fluor has failed to convince European officials that its patent for a chemical de-hydrogenation process is inventive, after opposition brought by the French branch of specialty materials maker Arkema Group.
-
September 05, 2025
Halozyme Defends Drug Delivery IP In Battle With Merck
Halozyme has denied claims that its patent for an under-the-skin drug delivery system should be nixed, asking a London court to stop Merck Sharp & Dohme from launching a new cancer drug that copies the technology.
-
September 04, 2025
ECJ Says Partners Can Represent Their Firms In EU Courts
The European Union's top court said Thursday that partners can represent their law firms before the bloc's courts as long as there is no "manifestly detrimental effect" on their capacity as a representative.
Expert Analysis
-
Strategies For Protecting Biotechnology In Brazil And China
Brazil and China have taken important steps to become significant contributors to the future success of the bioeconomy. Understanding options for quickly procuring and challenging patents in Brazil and China can be key for companies looking to expand their bioeconomy investments outside the U.S. and Europe, say attorneys with Sterne Kessler Goldstein & Fox PLLC.
-
How The FTC Has Erred On Innovation Policy Issues
Maureen Ohlhausen, the acting chairman of the Federal Trade Commission, recently delivered a sobering attack on the agency, noting that it and other antitrust agencies have “lost sight of core antitrust principles.” From such a highly competent federal official who is also a recognized legal scholar, this critique deserves our full attention, says David Teece, chairman of Berkeley Research Group LLC.
-
Dairy Vs. Plant-Based 'Milks': A Regulatory Standoff
Sales of nondairy milk alternatives are flourishing, but the dairy industry charges the U.S. Food and Drug Administration with failing to enforce its own labeling regulations regarding the definition of "milk." The longer terms like soy milk, almond milk and coconut milk remain in use, the stronger the argument for their continued use to describe these products, say attorneys with Shook Hardy & Bacon LLP.
-
UK Supreme Court Broadens Scope Of Patent Protection
The U.K. Supreme Court’s recent judgment in Actavis v. Eli Lilly sets out a revised approach to assessing patents in the U.K. and is likely to confer greater protection on patent owners, by providing that the protection afforded to a patent is not limited to the wording of the claims, say attorneys with Dechert LLP.
-
Brexit Creates Uncertainty For IP
Following Brexit, if the EU regulations directly applicable to intellectual property law are not transposed into English or Scottish law, a regulatory vacuum could be created. For patents, this could mean the first lack of substantive legal protection in over 700 years, says Roberta Young of Loza & Loza LLP.
-
Guest Feature
An Interview With Floyd Abrams
It was a privilege to spend a half-hour on the phone with the nation's foremost First Amendment lawyer. Floyd Abrams and I discussed his career, his new book and what he sees in his free-speech crystal ball. And he was a very good sport when I asked if it is constitutionally protected to yell inside a movie theater: “Citizens United is a terrible decision and should be set on fire,” says Randy Maniloff of White and Williams LLP.
-
An Interview With Ex-USPTO Director Todd Dickinson: Part 2
During a recent conversation with us, Q. Todd Dickinson, former director of the U.S. Patent and Trademark Office, offered his thoughts on intellectual property legislative and judicial activity in recent years, the policies that could use improvement, and the challenges that lie ahead for patent holders, say David Haas and Scott Weingust of Stout Risius Ross LLC.
-
An Interview With Ex-USPTO Director Todd Dickinson: Part 1
David Haas and Scott Weingust of Stout Risius Ross LLC recently had a candid discussion with Q. Todd Dickinson, former director of the U.S. Patent and Trademark Office and current head of Polsinelli PC’s intellectual property public policy practice. He shared his thoughts on the evolution of IP policy since his time at the PTO and his current concerns about U.S. patent law.
-
How China Became An IP Superpower
China has repeatedly been labeled an intellectual property pirate and wholesale IP rights violator, but those labels are no longer accurate. Today, applicants who overlook China do so at their peril, says Jay Erstling, of counsel at Patterson Thuente Pedersen PA and former director of WIPO's Patent Cooperation Treaty Office.
-
Real-World IP Tools In Virtual Worlds
Nonmillennials usually approach things like virtual reality from the perspective of what we know as the “real” world. We compare objects and interactions with how they would be if generated by Mother Nature. This is the greatest challenge for intellectual property professionals working in a virtual environment, say Elizabeth Ferrill of Finnegan Henderson Farabow Garrett & Dunner LLP and Joacim Lydén of Awapatent.
-
Filing Foreign Patents: 3rd-Party Disclosure Considerations
For U.S. patent applications filed following a disclosure of the invention, the one-year grace period provides a useful safety net. However, in other territories much stricter rules apply, say Hannah Buckley and Stuart Lumsden of Marks & Clerk.
-
EU May Soon Surpass US As Patent Center
Despite some uncertainty surrounding Brexit’s impact, the changing patent regime in Europe likely will make things easier for patent holders. Indeed, the new Unified Patent Court has several features that suggest it will be an appealing alternative to U.S. patent courts, say Ashley Keller and Katharine Wolanyk of Burford Capital LLC.
-
What To Expect From NPE Activity In China
An affiliate of nonpracticing entity Wi-LAN recently filed a patent suit against Sony in Nanjing, China. NPE activities have rarely been seen in China, so this raises the concern that international NPEs are now stepping in. Chinese patent litigation practice has two factors favorable to NPEs and two factors not favorable to NPEs, says Jackie Wong, legal counsel at Xiaomi Inc.
-
US Patent Practice Drifting Toward Approach Prevalent Abroad
Post-Alice cases on technical problems and technical solutions show that a problem-solution standard similar to the one adopted in Europe, Australia, China and Japan is seeing express endorsement by U.S. courts adjudicating Section 101 challenges, say Gurneet Singh and Harold Laidlaw of Mintz Levin Cohn Ferris Glovsky and Popeo PC.
-
Tips For Addressing The IP Challenges Of 3-D Printing: Part 1
The intellectual property rights of both manufacturers that use 3-D printing and manufacturers that don't may suffer through claim drafting that does not take into account the opportunities provided by 3-D manufacturing, say attorneys with Marks & Clerk.